GenScript is a biopharmaceutical research and development company, focusing on the fields of biotechnology and medical technology, providing users with services such as antibody drug development, gene cell therapy, and clinical sample production. Recently, Pengbo Biotech completed its C-round financing of US$220 million. This round of financing was led by Legend Capital, Honghui Fund, C&D Emerging Investment, Lianxin Capital, Service Trade Innovation Development Guidance Fund, Huatai Zijin, GF Xinde and Xingye Guoxin, and the old shareholder Hillhouse Investment once again participated in this round financing.
This article is transferred from: https://www.itjuzi.com/investevent/13782632
This site is only for collection, and the copyright belongs to the original author.